RBOT Dividend: Vicarious Surgical Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	21	13	21	0	0	0
Revenue Growth (YoY)	163%	-38%	--	--	--	--
Cost of Revenue	19	12	19	--	--	--
Gross Profit	2	1	2	--	--	--
Selling, General & Admin	24	26	33	36	16	3
Research & Development	37	40	47	43	22	9
Operating Expenses	42	53	61	80	38	12
Other Non Operating Income (Expenses)	0	0	5	84	3	--
Pretax Income	-59	-63	-71	5	-35	-12
Income Tax Expense	0	0	0	0	--	0
Net Income	-59	-63	-71	5	-35	-12
Net Income Growth	31%	-11%	-1,520%	-113.99%	192%	33%
Shares Outstanding (Diluted)	5.93	5.88	4.86	127.53	119.77	118.62
Shares Change (YoY)	-56%	21%	-96%	6%	1%	0%
EPS (Diluted)	-10.04	-10.74	-14.6	0.04	-0.29	-0.11
EPS Growth	196%	-26%	-36,608%	-113.99%	164%	38%
Free Cash Flow	-76	-50	-63	-66	-34	-12
Free Cash Flow Per Share	-12.79	-8.49	-12.94	-0.51	-0.28	-0.1
Gross Margin	9.52%	7.69%	9.52%	--	--	--
Operating Margin	-290.47%	-507.69%	-380.95%	0%	0%	0%
Profit Margin	-280.95%	-484.61%	-338.09%	0%	0%	0%
Free Cash Flow Margin	-361.9%	-384.61%	-300%	0%	0%	0%
EBITDA	-59	-64	-79	-79	-38	-12
EBITDA Margin	-280.95%	-492.3%	-376.19%	0%	0%	0%
D&A For EBITDA	2	2	1	1	0	0
EBIT	-61	-66	-80	-80	-38	-12
EBIT Margin	-290.47%	-507.69%	-380.95%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	--	0%

Vicarious Surgical Inc (RBOT) Price